It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Diabetes is a major health issue that affects people all over the world. Accurate early diagnosis is essential to enabling adequate therapy and prevention actions. Through the use of electronic health records and recent advancements in data analytics, there is growing interest in merging multimodal medical data to increase the precision of diabetes prediction. In order to improve the accuracy of diabetes prediction, this study presents a novel hybrid optimisation strategy that seamlessly combines machine learning techniques. In order to merge many models in a way that maximises efficiency while enhancing prediction accuracy, the study employs a collaborative learning technique. This study makes use of two separate diabetes database datasets from Pima Indians. A feature selection process is used to streamline error-free classification. A third method known as Binary Grey Wolf-based Crow Search Optimisation (BGW-CSO), which was produced by merging the Binary Grey Wolf Optimisation Algorithm (BGWO) and Crow Search Optimisation (CSO), is provided to further enhance feature selection capabilities. This hybrid optimisation approach successfully solves the high-dimensional feature space challenges and enhances the generalisation capabilities of the system. The Support Vector Machine (SVM) method is used to analyse the selected characteristics. The performance of conventional SVMs is enhanced by the newly created BGW-CSO technique, which optimises the number of hidden neurons within the SVM. The proposed method is implemented using Python software. The suggested BGW-CSO-SVM approach outperforms the current methods, such as Soft Voting Classifier, Random Forest, DMP_MI, and Bootstrap Aggregation, with a remarkable accuracy of 96.62%. Comparing the suggested BGW-CSO-SVM approach to the other methods, accuracy shows an average improvement of around 16%. Comparative evaluations demonstrate the suggested approach's improved performance and demonstrate its potential for real-world use in healthcare settings.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer